Article PDF
Avoid common mistakes on your manuscript.
References
Garrido P, de Castro J, Concha Á et al (2012) Guidelines for biomarker testing in advanced non-small-cell lung cancer (NSCLC). A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP). Clin Transl Oncol 14:338–349
Felip E, Gridelli C, Baas P et al; panel members (2010) Metastatic non-small cell lung cancer: consensus on pathology and molecular tests, first line, second line, and third line. 1st ESMO Consensus Conference in Lung Cancer, Lugano 2010. Ann Oncol 22:1507–1519
Pirker R, Herth F, Kerr K et al; European EGFR Workshop (2010) Consensus for EGFR mutation testing in non-small cell lung cancer. Results from a European Workshop. J Thorac Oncol 5: 1706–1712
Thunnisson E, Kerr, K, Herth F et al (2012) The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 76:1–18
Sequist LV, Heist RS, Shaw AT et al (2011) Implementing multiplexed genotyping on non-small cell lung cancer in routine clinical practice. Ann Oncol 22:2616–2624
Polity K, Lynch TJ (2012) Two sides of the same coin: EGFR exon 19 deletions and insertions in lung cancer. Clin Cancer Res [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stahel, R. Biomarker testing in non-small cell lung cancer: to move forward with quality. Clin Transl Oncol 14, 321–322 (2012). https://doi.org/10.1007/s12094-012-0802-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-012-0802-6